4Mon
It's really cool what micro-caps you always land. There must have been some insider buying recently: https://m.de.investing.com/news/insider-trading-news/myomodirektor-kirk-thomas-f-kauft-aktien-im-wert-von-68242--93CH-3488408?ampMode=1
•
44
•4Mon
@jkb92 also put in 500 :)
•
11
•
@jkb92 Ah okay, I had forgotten, with your permission, I'll include the link :)
•
22
•@jkb92 I am also specifically looking for investments that deal with niches, away from the AI hype.
But thanks for the praise :) that motivates me
But thanks for the praise :) that motivates me
•
11
•4Mon
@Raketentoni clear :)
•
11
•4Mon
@Raketentoni Yes, I think that's cool. Dessert Control is now moving in the right direction again after the strong dip.
•
22
•@jkb92 Today it's going up again, by the way, nice report on why big players are also getting in:
https://finance.yahoo.com/markets/stocks/articles/myomo-myo-shows-fast-paced-125502252.html
@Get_Rich_or_Die_Tryin @Tenbagger2024
https://finance.yahoo.com/markets/stocks/articles/myomo-myo-shows-fast-paced-125502252.html
@Get_Rich_or_Die_Tryin @Tenbagger2024
•
22
•
@Raketentoni I also see a lot of potential here. I think we could perhaps also benefit from the problems that occurred at Otto Bock. There should also be a lack of confidence in Otto Bock. And then investors will look for new players in the sector. But that also speaks for the company. Is there also a humanoid robot area here, it would be exciting to be able to control a humanoid by thought
•
11
•@Tenbagger2024 But Otto Bock makes prostheses. Myomo makes your arm or leg usable again, a completely different approach. :)
••
@Raketentoni but I think I once read that Otto Bock is also in this area. But I'm not 100% sure about that.
••
@Tenbagger2024 Although both companies work in the field of mobility aids for people with physical disabilities, the differences from an investor's point of view - and technologically - could hardly be greater.Here is the direct comparison between the giant Ottobock and your investment Myomo (MYO):1. The business model & The size (Dino vs. Speedboat)Ottobock (The "medium-sized giant"): Ottobock is the global market leader in prosthetics (artificial limbs) and orthotics (splints/corsets). The company is over 100 years old, has over 9,000 employees and an annual turnover of well over one billion euros. They have a broad base: They make everything from mechanical wheelchairs to carbon prostheses for Paralympic athletes to highly complex computer-controlled leg systems (such as the famous C-Brace). Myomo (your investment): Myomo is a highly specialized medical robotics company (wearable robotics) from the USA. Compared to Ottobock, Myomo is tiny (micro-cap). They basically focus on a single, groundbreaking product: the MyoPro arm brace. 2. the technological difference (replacement vs. "power steering" for paralyzed arms)Ottobock's focus: Ottobock has traditionally been gigantically strong in replacing lost limbs (prosthetics). When they build splints (orthoses), these are mostly used for stabilization (e.g. after a stroke for the legs). The focus of Myomo (MyoPro): Myomo attacks where Ottobock had little to offer for a long time: paralyzed or extremely weakened but still present arms (e.g. after a stroke, traumatic brain injury or plexus palsy). The magic behind it: The MyoPro brace uses non-invasive sensors on the skin to read the tiny electromyographic (EMG) nerve signals that the brain sends to the paralyzed arm. Built-in electric motors immediately amplify this signal and move the arm in the way the patient actually intended. It is a kind of "power steering" for paralyzed limbs. 3. latest development: not enemies, but partners! the best thing about your investment is that the two companies don't tear each other apart, but complement each other perfectly. hot news from may 2026: Myomo just announced a massive expansion of its partnership with Ottobock a few weeks ago. The MyoPro arm orthoses are now being sold and fitted in Ottobock Care clinics across the USA. Ottobock is therefore using Myomo to position its own clinics as the absolute market leader for neuro-robotic solutions, as they have nothing comparable on the shelves, even in the upper extremity (arm) sector. In turn, this gives Myomo immediate access to Ottobock's gigantic sales and clinic network.
••